Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia: A Comparison of Treatment Outcomes in Clinical Trial Participants vs Medicare Beneficiaries
JAMA Oncol 2019 Dec 19;[EPub Ahead of Print], ST Bird, F Tian, N Flowers, D Przepiorka, R Wang, TH Jung, Z Kessler, C Woods, B Kim, BW Miller, M Wernecke, C Kim, S McKean, K Gelperin, TE MaCurdy, JA Kelman, DJ GrahamFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.